Expect to See More Patients Switch From a Biologic to a Biosimilar

August 2019

More questions will come up about biosimilars...now that BC will require patients to switch to biosimilars to save healthcare dollars.

Biosimilars are biologics that are highly SIMILAR to the original, or "reference," biologic...but cost up to 50% less.

For example, patients in BC who take Lantus for diabetes may switch to the biosimilar Basaglar. Both contain insulin glargine...but Basaglar is about $15/pen versus $20/pen for Lantus.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Medication Errors Prevent Mishaps With Meds That Patients Need to Mix Before Use
Photosensitivity Watch for Meds That Make Patients More Prone to Sun Sensitivity
Opioids Don't Think of Tramadol as a "Safer" Opioid
Biosimilars Expect to See More Patients Switch From a Biologic to a Biosimilar
Diabetes Look Out for Mix-Ups With GLP-1 Agonists for Diabetes
Cannabinoids Include Use of Recreational Cannabis on Profiles for Patients With Diabetes
Patient Safety Get the Facts About Stem Cells
OTC Products Steer Patients Looking for Gentian Violet to the Pharmacist
Pregnancy Stay Alert for OTC GI Meds That Pose Risks in Pregnancy
Lupus Know How Meds for Lupus Stack Up

Expect to See More Patients Switch From a Biologic to a Biosimilar

Practical advice for a better career, with unlimited access to CE

Table of Contents